Thus, ANP is a highly attractive candidate for future cancer therapies as it mediates antiproliferative and anti‐inflammatory effects and offers the potential to circumvent cytotoxic side effects of conventionally used chemotherapeutics such as cisplatin, also used in RB therapy. Here, NPPA is linked to retinoblastoma.